DMD and Duchenne muscular dystrophy: The robustness of our findings is underscored by the fact that we used hiPSC lines from six DMD and six controls, generated in four different labs from four diverse starting cell types, including two isogenic lines comprised of CRISPR-corrected DMD mutations and one isogenic line that was a CRISPR-created mutant.